Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
Conditions
Interventions
Intervention1: Idi Vallathy Mezhugu: 0.8 gm of Trial Drug Administration twice a day Orally for 48 Days
Intervention2: Idi Vallathy Mezhugu: 0.8 gram of trial drug administration twice a day orally fo
Sponsors
National Institute of Siddha
Eligibility
Inclusion criteria
Inclusion criteria: Both sexes of age between 16 to 60. Patient who meets the standard, European League against Rheumatism EULAR 2010 classification criteria. A score >= 6 points is required for classification as definite RA. Patients who are willing to attend OPD and IPD Patients who are willing to undergo laboratory investigation. Patient who are willing to sign the informed consent stating that he/ she will consciously stick to the treatment during 48 days but can stop out of the trail of his /her own conscious discretion. Patients who are willing to follow diet restriction
Exclusion criteria
Exclusion criteria: Known C/O Other Auto immune diseases. Patients receiving immunosuppressant, corticosteroids, antipsychotics, other arthritis medications including painkillers. Known C/O Systemic Hypertension (SHT) Known C/O Diabetes Pregnant women. Lactating women. History of trauma Known C/O Any other arthritis Systemic complication of rheumatoid arthritis Patient. Characteristic deformities of hand and feet in Rheumatoid Arthritis Known C/O any other serious systemic illness like Cancer, Cardiac disease, Renal disease, Liver disorders, Neurological disorders. Patients who had already participated in a new drug study in the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of EULAR Score and Clinical Symptoms from Baseline Visit to End Visit. This Study Will Discover the Therapeutic Effectiveness of also Helps to Maximize the Quality of Life and Reduce the Burden of RA Patient. Timepoint: One Month - Screening Three Month - Enrollment One Month - Assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| To record if any adverse reactionTimepoint: four months;To Record If any Any Adverse ReactionTimepoint: Four month | — |
Countries
India
Contacts
Public ContactDr Sivakkumar
National Institute of Siddha
Outcome results
None listed